Previous close | 94.25 |
Open | 94.69 |
Bid | 92.50 x 900 |
Ask | 94.70 x 900 |
Day's range | 92.84 - 94.98 |
52-week range | 92.63 - 136.48 |
Volume | |
Avg. volume | 693,772 |
Market cap | 9.622B |
Beta (5Y monthly) | 1.18 |
PE ratio (TTM) | 11.03 |
EPS (TTM) | 8.56 |
Earnings date | 27 Apr 2022 - 02 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 122.25 |
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
DaVita Inc. ( NYSE:DVA ) shareholders have seen the share price descend 14% over the month. But that doesn't undermine...
Despite strength in dialysis patient service revenues, DaVita (DVA) records an overall soft Q1 performance.